Vivos Therapeutics, Inc. (VVOS)
0.2765
-0.02
(-6.90%)
USD |
NASDAQ |
Aug 24, 16:00
0.2735
0.00 (0.00%)
After-Hours: 20:00
Vivos Therapeutics Enterprise Value : 15.98M for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 15.98M |
| August 20, 2026 | 15.72M |
| August 19, 2026 | 15.67M |
| August 18, 2026 | 15.94M |
| August 17, 2026 | 16.04M |
| August 14, 2026 | 16.65M |
| August 13, 2026 | 16.10M |
| August 12, 2026 | 15.82M |
| August 11, 2026 | 16.24M |
| August 10, 2026 | 16.28M |
| August 07, 2026 | 16.37M |
| August 06, 2026 | 16.34M |
| August 05, 2026 | 16.61M |
| August 04, 2026 | 18.38M |
| August 03, 2026 | 17.78M |
| July 31, 2026 | 17.62M |
| July 30, 2026 | 17.56M |
| July 29, 2026 | 17.68M |
| July 28, 2026 | 17.77M |
| July 27, 2026 | 17.52M |
| July 24, 2026 | 17.38M |
| July 23, 2026 | 17.34M |
| July 22, 2026 | 17.54M |
| July 21, 2026 | 17.69M |
| July 20, 2026 | 17.64M |
| Date | Value |
|---|---|
| July 17, 2026 | 17.76M |
| July 16, 2026 | 17.66M |
| July 15, 2026 | 17.67M |
| July 14, 2026 | 17.62M |
| July 13, 2026 | 17.76M |
| July 10, 2026 | 17.94M |
| July 09, 2026 | 18.43M |
| July 08, 2026 | 18.64M |
| July 07, 2026 | 18.63M |
| July 06, 2026 | 18.68M |
| July 02, 2026 | 18.25M |
| July 01, 2026 | 18.91M |
| June 30, 2026 | 18.27M |
| June 29, 2026 | 16.68M |
| June 26, 2026 | 16.07M |
| June 25, 2026 | 15.88M |
| June 24, 2026 | 15.98M |
| June 23, 2026 | 16.32M |
| June 22, 2026 | 15.45M |
| June 18, 2026 | 16.77M |
| June 17, 2026 | 16.92M |
| June 16, 2026 | 17.37M |
| June 15, 2026 | 17.81M |
| June 12, 2026 | 17.74M |
| June 11, 2026 | 18.31M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Hinge Health, Inc. | 6.708B |
| Exlites Holdings International, Inc. | 15.42M |
| Xcelerate, Inc. | 5.997M |
| Haemonetics Corp. | 5.898B |
| Pro-Dex, Inc. | 219.11M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.523M |
| Revenue (Quarterly) | 5.153M |
| Total Expenses (Quarterly) | 10.63M |
| EPS Diluted (Quarterly) | -0.31 |
| Gross Profit Margin (Quarterly) | 47.41% |
| Profit Margin (Quarterly) | -107.2% |
| Earnings Yield | -748.6% |
| Normalized Earnings Yield | -752.88 |